The Asia Pacific Bunion Correction Systems Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
The availability of minimally invasive surgical techniques to treat the illness is anticipated to boost market expansion. For instance, Zimmer Biomet's Re+Line a Bunion Correction Systems is a compression plate that requires little to no incision during bunion surgery. Using Guide Technology, the system is created for simple medial positioning and insertion.
Additionally, the Food and Drug Administration's expansion of product approvals is anticipated to support the market's expansion. For instance, a medical device business called Treace Medical Concepts Inc. in June 2019 got approval for its Lapiplasty 3D Bunion Correction Systems intended for children over the age of 12. The technique is made to address all three aspects of a bunion deformity, which are the condition's primary causes.
The Asia Pacific region is home to some of the world's most advanced bunion correction systems. These systems are used to treat a wide range of bunion deformities, from mild to severe. These systems typically involve the use of a special device that is inserted into the big toe joint. This device realigns the joint and helps to correct the bunion deformity. In some cases, surgery may also be required.
The China market dominated the Asia Pacific Bunion Correction Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $70.9 million by 2028. The Japan market is estimated to grow a CAGR of 7.4% during (2022-2028). Additionally, The India market would experience a CAGR of 8.7% during (2022-2028).
Based on Product, the market is segmented into Wearables and Implants & Accessories. Based on End-Use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
The availability of minimally invasive surgical techniques to treat the illness is anticipated to boost market expansion. For instance, Zimmer Biomet's Re+Line a Bunion Correction Systems is a compression plate that requires little to no incision during bunion surgery. Using Guide Technology, the system is created for simple medial positioning and insertion.
Additionally, the Food and Drug Administration's expansion of product approvals is anticipated to support the market's expansion. For instance, a medical device business called Treace Medical Concepts Inc. in June 2019 got approval for its Lapiplasty 3D Bunion Correction Systems intended for children over the age of 12. The technique is made to address all three aspects of a bunion deformity, which are the condition's primary causes.
The Asia Pacific region is home to some of the world's most advanced bunion correction systems. These systems are used to treat a wide range of bunion deformities, from mild to severe. These systems typically involve the use of a special device that is inserted into the big toe joint. This device realigns the joint and helps to correct the bunion deformity. In some cases, surgery may also be required.
The China market dominated the Asia Pacific Bunion Correction Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $70.9 million by 2028. The Japan market is estimated to grow a CAGR of 7.4% during (2022-2028). Additionally, The India market would experience a CAGR of 8.7% during (2022-2028).
Based on Product, the market is segmented into Wearables and Implants & Accessories. Based on End-Use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
Scope of the Study
By Product
- Wearables
- Implants & Accessories
By End-use
- Hospitals
- Ambulatory Centers
- Specialty Centers
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Stryker Corporation
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- Extremity Medical, LLC.
- Acumed, LLC.
- De Puy Synthes (Johnson & Johnson)
- BioPro, Inc.
- Orthofix Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Bunion Correction Systems Market by Product
Chapter 5. Asia Pacific Bunion Correction Systems Market by End-use
Chapter 6. Asia Pacific Bunion Correction Systems Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Stryker Corporation
- Arthrex, Inc.
- Zimmer Biomet Holdings, Inc.
- Extremity Medical, LLC.
- Acumed, LLC.
- De Puy Synthes (Johnson & Johnson)
- BioPro, Inc.
- Orthofix Medical, Inc.
Methodology
LOADING...
